The Future of Medicine: A Conversation about AM in Healthcare with Mark Morrison, Smith & Nephew

Additive Snack

As additive manufacturing (AM) practices and processes mature, we are reminded daily of the boundless potential and transformative power of technology, especially in the healthcare industry. However, additive manufacturing can be a confusing arena for traditional medical manufacturers to step into. Large organizations that successfully integrate additive are essential components of the technology’s wider adoption.

Joining Host Fabian Alefeld is Mark Morrison, Senior Research Manager at Smith & Nephew. Mark has decades of experience in both additive manufacturing and material science. Their conversation explores the significance of material science in AM, Mark’s unique journey, and sheds light on Smith & Nephew’s achievements including producing hundreds of thousands of patient-specific applications. Mark highlights key applications driving AM adoption and the importance of porous structures in the medical space. They also address the patient-specific perspective, the challenges of integrating AM into big business, and how the industry is navigating the experience gap between traditional methods and modern industrial 3D printing.

All opinions expressed by podcast participant(s) are so current opinions and do not reflect the opinions of EOS GmbH or the podcast participant(s) respective companies and/or affiliates.

Comments about the show or wish to share your AM journey? Contact us at [e-mail]. The Additive Snack Podcast is brought to you by EOS.

Key Takeaways:

[1:55] Mark’s appreciation for understanding why things behave the way they do triggered his journey into material science and additive manufacturing.

[5:03] In the medical industry, what current applications can be enhanced by additive manufacturing, and what are the patient benefits?

[10:33] What challenges or limitations does Mark foresee for integrating additive manufacturing more broadly in the medical space?

[15:46] What role does the FDA play in assisting organizations to qualify additively manufactured implants to make them market-ready?

[19:31] What excites Mark when he thinks about current and future additive applications?